Association of Hyperuricemia With Proteinuria in Patients with Type 2 Diabetes Mallitus Experience of Tertiary Care Hospital
DOI:
https://doi.org/10.54112/bcsrj.v6i3.1639Keywords:
Diabetic Nephropathies, Hyperuricemia, Albuminuria, Type 2 Diabetes Mellitus, Uric AcidAbstract
Diabetic nephropathy is a leading cause of chronic kidney disease and end-stage renal failure in patients with type 2 diabetes mellitus (T2DM). Albuminuria is an early marker of renal damage, while hyperuricemia has been increasingly recognized as a possible risk factor for kidney disease progression. Objective: To evaluate the relationship between elevated serum uric acid levels and the presence and severity of albuminuria in patients with type 2 diabetes. Methods: A retrospective, hospital-based study was conducted at Ziauddin University Hospital, Clifton Campus during June 2024 till November 2024. A total of 400 patients with T2DM were included using non-probability purposive sampling. Inclusion criteria were age >18 years, confirmed T2DM, serum uric acid ≥7 mg/dL, and spot urine albumin–creatinine ratio (UACR) >30 mg/g. Patients with UTI, stage 5 CKD, autoimmune disease, malignancy, or on medications affecting uric acid levels were excluded. Results: The mean serum uric acid level was 7.8 ± 0.6 mg/dL, and the mean UACR was 154.6 ± 85.2 mg/g. Macroalbuminuria was present in 30.5% of patients. The frequency of macroalbuminuria increased significantly with higher uric acid levels (p < 0.001). A significant positive correlation was observed between serum uric acid and UACR (r = 0.42, p < 0.001). Stratified analysis showed higher rates of macroalbuminuria among patients with longer diabetes duration and poorer glycemic control. Conclusion: It is concluded that hyperuricemia is significantly associated with increased albuminuria in patients with type 2 diabetes. Monitoring and managing serum uric acid levels may serve as a valuable approach in the early identification and prevention of diabetic nephropathy.
Downloads
References
Fatima, S., Raza, H., & Khan, D. A. (2020). Association of hyperuricemia with microalbuminuria in patients with type 2 diabetes mellitus. Pakistan Journal of Medical Sciences, 36(3), 362–366. https://doi.org/10.12669/pjms.36.3.1877
Cao, Z., & Cooper, M. E. (2011). Pathogenesis of diabetic nephropathy. Journal of Diabetes Investigation, 2(4), 243–247. https://doi.org/10.1111/j.2040-1124.2011.00137.x
Behradmanesh, S., Horestani, M. K., Baradaran, A., & Nasri, H. (2013). Association of serum uric acid with proteinuria in type 2 diabetic patients. Journal of Nephropathology, 2(3), 126–133. https://doi.org/10.5812/nephropathol.10239
Bonakdaran, S., Hami, M., & Shakeri, M. T. (2011). Hyperuricemia and albuminuria in patients with type 2 diabetes mellitus. Iranian Journal of Kidney Diseases, 5(1), 21–24. (No DOI available; found in IRJKD archives)
Chen, L., Huang, L., Wu, Y., & Duan, Z. (2021). Association between uric acid level and incidence of albuminuria in patients with type 2 diabetes mellitus. Medicine, 100(50), e27841. https://journals.lww.com/md-journal/fulltext/2021/10150/association_between_uric_acid_level_and_incidence.31.aspx
Tseng, C. H. (2013). Hyperuricemia is an independent risk factor for new-onset microalbuminuria in a middle-aged and elderly population: A prospective cohort study in Taiwan. PLoS One, 8(4), e61450. https://doi.org/10.1371/journal.pone.0061450
Khan S, Qayyum S, Khan MNA. Triglyceride-glucose index: A surrogate marker of homeostasis model assessment of insulin resistance to predict diabetic nephropathy. J Pak Med Assoc. 2024 May;74(5):862-867. doi: 10.47391/JPMA.8505. PMID: 38783431.
Hassan Al-Bayati AA, Jawad Al-Khateeb SM. The association between glycaemic level and lipid profile with Albuminuria in Iraqi type 2 diabetes patients - A cross-sectional study. J Pak Med Assoc. 2021 Dec;71(Suppl 8)(12):S57-S62. PMID: 35130220.
Idowu AA, Ajose AO, Adedeji AT, Adegoke AO, Jimoh KA. Microalbuminuria, Other Markers of Nephropathy and Biochemical Derangements in Type 2 Diabetes Mellitus: Relationships and Determinants. Ghana Med J. 2017 Jun;51(2):56-63. PMID: 28955101; PMCID: PMC5611905.
Xia F, Liu G, Shi Y, Zhang Y. Impact of microalbuminuria on incident coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis of prospective studies. Int J Clin Exp Med. 2015 Jan 15;8(1):1–9. eCollection 2015
Chen CC, Susanto H, Chuang WH, Liu TY, Wang CH. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function. Cardiovasc Diabetol. 2016 Jan 7;15:3. Doi: 10.1186/s12933-015-0326-9. Erratum in: Cardiovasc Diabetol. 2017 Apr 26;16(1):58. doi: 10.1186/s12933-017-0538-2. PMID: 26739836; PMCID: PMC4704426.
Qiao YC, Chen YL, Pan YH, Ling W, Tian F, Zhang XX, Zhao HL. Changes of transforming growth factor beta 1 in patients with type 2 diabetes and diabetic nephropathy: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2017 Apr;96(15):e6583. doi: 10.1097/MD.0000000000006583. PMID: 28403088; PMCID: PMC5403085.
Emara AM, El Bendary AS, Ahmed LM, Okda HI. Evaluation of serum levels of sestrin two and betatrophin in type 2 diabetic patients with diabetic nephropathy. BMC Nephrol. 2024 Jul 19;25(1):231. doi: 10.1186/s12882-024-03663-2. PMID: 39030467; PMCID: PMC11264897.
Singh, Kuldeep1; Kumar, Pardeep1; Joshi, Arun2; Shivhare, Dileep Kumar3; Mahto, Subodh Kumar1,; Singh, Akanskha1; Aneja, Ankita1; Lamba, Brinder Mohan Singh1. Study of association of serum uric acid with albuminuria and carotid atherosclerosis in type 2 diabetes mellitus patients. Journal of Family Medicine and Primary Care 8(12):p 4027-4031, December 2019. | DOI: 10.4103/jfmpc.jfmpc_777_19
Lai, Yun-Ju MD, PhDa,b,c,d; Chen, Yu-Yen MD, PhDa,e,f,g,h; Ku, Po-Wen PhDi; Chen, Li-Jung PhDc; Yen, Yung-Feng MD, PhDd,j,k,∗. Association between uric acid level and incidence of albuminuria in patients with type 2 diabetes mellitus: A 4.5-year cohort study. Medicine 100(41):p e27496, October 15, 2021. | DOI: 10.1097/MD.0000000000027496.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Mahnoor Shah, Muhammad Ali Kamran, Umer Jehangir, Shard Kumar Bansari, Alina Saeed

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.